News
5 Most-Loved ETFs of Last Week
Boost Your Portfolio with Our Top ETF Insights
Zacks' exclusive Fund Newsletter delivers actionable information, top news and analysis, as well as top-performing ETFs, straight to your inbox
Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes
The Chemours Company CC reported a net loss of $381 million or $2.54 per share for second-quarter 2025, in contrast to the year-ago quarter's net income of $60 million or 39 cents.
Barring one-time
Does U.S. Physical Therapy (USPH) Have the Potential to Rally 26.48% as Wall Street Analysts Expect?
U.S. Physical Therapy (USPH) closed the last trading session at $86.71, gaining 17.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set
Wall Street Analysts See a 31.2% Upside in HCI Group (HCI): Can the Stock Really Move This High?
Shares of HCI Group (HCI) have gained 9.3% over the past four weeks to close the last trading session at $154.34, but there could still be a solid upside left in the stock if short-term price
Does VAREX IMAGING (VREX) Have the Potential to Rally 71.44% as Wall Street Analysts Expect?
Shares of VAREX IMAGING (VREX) have gained 23.2% over the past four weeks to close the last trading session at $9.77, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Believe SunOpta (STKL) Could Rally 60.26%: Here's is How to Trade
SunOpta (STKL) closed the last trading session at $6.24, gaining 1.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Carriage Services (CSV) Could Rally 27.04%: Here's is How to Trade
Shares of Carriage Services (CSV) have gained 1.2% over the past four weeks to close the last trading session at $47.49, but there could still be a solid upside left in the stock if short-term price
Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know
Shares of BioLife Solutions, Inc. (BLFS) have gained 1.6% over the past four weeks to close the last trading session at $22.37, but there could still be a solid upside left in the stock if
How Much Upside is Left in a.k.a. Brands (AKA)? Wall Street Analysts Think 84.68%
a.k.a. Brands (AKA) closed the last trading session at $11.1, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Does Peloton (PTON) Have the Potential to Rally 26.06% as Wall Street Analysts Expect?
Shares of Peloton (PTON) have gained 28.1% over the past four weeks to close the last trading session at $8.25, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know
Shares of AxoGen (AXGN) have gained 16.6% over the past four weeks to close the last trading session at $14.01, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Predict a 25.69% Upside in Embecta Corp. (EMBC): Here's What You Should Know
Embecta Corp. (EMBC) closed the last trading session at $12.73, gaining 22.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall
Here's Why CB Financial Services (CBFV) Is a Great 'Buy the Bottom' Stock Now
A downtrend has been apparent in CB Financial Services (CBFV) lately. While the stock has lost 5.3% over the past two weeks, it could witness a trend reversal as a hammer chart pattern was formed in
How Much Upside is Left in Enerflex (EFXT)? Wall Street Analysts Think 28.79%
Enerflex (EFXT) closed the last trading session at $9.17, gaining 13.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Rapt Therapeutics (RAPT)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Rapt Therapeutics (RAPT) could be a good stock pick from a technical perspective. RAPT recently experienced a "golden cross" event, which saw its 50-day
Here's Why German American Bancorp (GABC) Is a Great 'Buy the Bottom' Stock Now
A downtrend has been apparent in German American Bancorp (GABC) lately. While the stock has lost 6.8% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed
Zymeworks (ZYME) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
The price trend for Zymeworks Inc. (ZYME) has been bearish lately and the stock has lost 7.6% over the past two weeks. However, the formation of a hammer chart pattern in its last trading session
Q2 in the Rearview: Is COP a Smart Hold Stock or a Hot Chase?
Last Thursday, ConocoPhillips COP reported second-quarter 2025 earnings, which exceeded expectations. This was driven by higher oil-equivalent production volumes, especially from the Lower 48, which
How Should You Play RTX Stock Following Its DARPA Contract Win?
RTX Corp.’s (RTX) BBN Technologies company has recently secured a DARPA contract for the Intelligent Generation of Tools for Security program, aimed at strengthening cybersecurity by automating the
Cheniere Energy Lands New LNG Supply Deal With JERA Starting 2029
Cheniere Energy Inc. LNG has signed a long-term sales and purchase agreement (SPA) with JERA, a Japanese energy firm, for the supply of liquefied natural gas. The deal was secured by Cheniere
LRCX's ALD Moly Adoption Ramps Up: Will it be a Key Growth Driver?
Lam Research LRCX is growing its position in molybdenum (moly) deposition, a technology that could increase its share of the chip equipment market. Lam Research is currently the only supplier with
Why Verizon Communications (VZ) is a Top Momentum Stock for the Long-Term
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.
The popular research
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different


